[go: up one dir, main page]

PL2101766T3 - Kompozycje i sposoby stosowania (R)-pramipeksolu - Google Patents

Kompozycje i sposoby stosowania (R)-pramipeksolu

Info

Publication number
PL2101766T3
PL2101766T3 PL07855182T PL07855182T PL2101766T3 PL 2101766 T3 PL2101766 T3 PL 2101766T3 PL 07855182 T PL07855182 T PL 07855182T PL 07855182 T PL07855182 T PL 07855182T PL 2101766 T3 PL2101766 T3 PL 2101766T3
Authority
PL
Poland
Prior art keywords
pramipexole
compositions
methods
Prior art date
Application number
PL07855182T
Other languages
English (en)
Inventor
Michael E. Bozik
Thomas Petzinger Jr.
Valentin Gribkoff
Original Assignee
Knopp Biosciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/733,642 external-priority patent/US20070259930A1/en
Priority claimed from US11/749,497 external-priority patent/US8017598B2/en
Application filed by Knopp Biosciences Llc filed Critical Knopp Biosciences Llc
Priority claimed from EP07855182.7A external-priority patent/EP2101766B1/en
Publication of PL2101766T3 publication Critical patent/PL2101766T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL07855182T 2006-12-14 2007-12-14 Kompozycje i sposoby stosowania (R)-pramipeksolu PL2101766T3 (pl)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US87000906P 2006-12-14 2006-12-14
US89483507P 2007-03-14 2007-03-14
US89482907P 2007-03-14 2007-03-14
US89479907P 2007-03-14 2007-03-14
US11/733,642 US20070259930A1 (en) 2006-04-10 2007-04-10 Compositions and methods of using r(+) pramipexole
US11/749,497 US8017598B2 (en) 2006-05-16 2007-05-16 Compositions of R(+) and S(−) pramipexole and methods of using the same
US97904907P 2007-10-10 2007-10-10
EP07855182.7A EP2101766B1 (en) 2006-12-14 2007-12-14 Compositions and methods of using (r)-pramipexole

Publications (1)

Publication Number Publication Date
PL2101766T3 true PL2101766T3 (pl) 2017-04-28

Family

ID=46640468

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07855182T PL2101766T3 (pl) 2006-12-14 2007-12-14 Kompozycje i sposoby stosowania (R)-pramipeksolu

Country Status (2)

Country Link
EP (5) EP2465500A1 (pl)
PL (1) PL2101766T3 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
DK2026803T3 (da) 2006-05-16 2012-04-16 Knopp Neurosciences Inc Sammensætninger af R(+) og S(-) pramipexol og fremgangsmåder til anvendelse heraf
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
AU2008224844B2 (en) 2007-03-14 2012-08-09 Knopp Neurosciences, Inc. Synthesis of chirally purified substituted benzothiazole diamines
JP2012500283A (ja) 2008-08-19 2012-01-05 ノップ ニューロサイエンシーズ、インク． （ｒ）−プラミペキソールを使用した組成物並びにその方法
WO2013096816A1 (en) 2011-12-22 2013-06-27 Biogen Idec Ma Inc. Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
SI3838271T1 (sl) 2013-07-12 2025-12-31 Areteia Therapeutics, Inc. Zdravljenje povišanih ravni eozinofilcev in/ali bazofilcev
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
PT3033081T (pt) 2013-08-13 2021-06-01 Knopp Biosciences Llc Composições e métodos para o tratamento da urticária crónica
AU2014306683B2 (en) 2013-08-13 2017-10-12 Knopp Biosciences Llc Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
US11318122B2 (en) 2017-04-13 2022-05-03 Chase Therapeutics Corporation Pharmaceutical combination and its use for treating synucleinopathties
CN112858527B (zh) * 2021-03-08 2022-11-01 成都倍特药业股份有限公司 盐酸普拉克索缓释片有关物质的检测方法
CN115260119B (zh) * 2022-07-26 2023-02-10 山东京卫制药有限公司 一种普拉克索昔萘酸盐及其药物缓释制剂

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0186087B1 (de) 1984-12-22 1989-08-23 Dr. Karl Thomae GmbH Tetrahydro-benzthiazole, deren Herstellung und deren Verwendung als Zwischenprodukte oder als Arnzneimittel
US5453601A (en) 1991-11-15 1995-09-26 Citibank, N.A. Electronic-monetary system
US6156777A (en) * 1994-12-15 2000-12-05 Pharmacia & Upjohn Company Use of pramipexole as a neuroprotective agent
US6322819B1 (en) 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
US6955821B2 (en) 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US20020177626A1 (en) 2001-01-19 2002-11-28 Cook Graham D. Treatment of sleep disturbances
GB0117618D0 (en) 2001-07-19 2001-09-12 Phoqus Ltd Pharmaceutical dosage form
US7157480B2 (en) * 2001-12-11 2007-01-02 University Of Virginia Patent Foundation Use of pramipexole to treat amyotrophic lateral sclerosis
DK1467712T4 (da) 2002-01-16 2011-11-21 Boehringer Ingelheim Pharma Fremgangsmåde til at fremstille en tolags farmaceutisk tablet omfattende telmisartan og hydrochlorthiazid
WO2004112756A1 (en) 2003-06-26 2004-12-29 Isa Odidi Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US20050053649A1 (en) 2003-09-08 2005-03-10 Anne-Marie Chalmers Medication delivery device
US20050220877A1 (en) 2004-03-31 2005-10-06 Patel Ashish A Bilayer tablet comprising an antihistamine and a decongestant
US7539203B2 (en) 2004-05-26 2009-05-26 Intel Corporation Multiple channel flow control with first-in-first-out (FIFO) read/write random access memory (RAM)
NZ553645A (en) * 2004-08-13 2010-09-30 Boehringer Ingelheim Int Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
DK1814527T4 (da) 2004-11-05 2020-12-07 Boehringer Ingelheim Int Dobbeltlagstablet omfattende telmisartan og amlodipin
WO2006070406A1 (en) 2004-12-29 2006-07-06 J.B. Chemicals & Pharmaceuticals Ltd Bilayer tablets of oxcarbazepine for controlled delivery and a process of preparation thereof
JP2009504748A (ja) * 2005-08-15 2009-02-05 ユニバーシティ オブ バージニア パテント ファウンデーション Ｒ（＋）プラミペキソールを用いた神経回復
US20070259930A1 (en) * 2006-04-10 2007-11-08 Knopp Neurosciences, Inc. Compositions and methods of using r(+) pramipexole
DK2026803T3 (da) * 2006-05-16 2012-04-16 Knopp Neurosciences Inc Sammensætninger af R(+) og S(-) pramipexol og fremgangsmåder til anvendelse heraf

Also Published As

Publication number Publication date
EP2508181A1 (en) 2012-10-10
EP2465500A1 (en) 2012-06-20
EP2497474A1 (en) 2012-09-12
EP2497472A1 (en) 2012-09-12
EP2497473A1 (en) 2012-09-12

Similar Documents

Publication Publication Date Title
PT2101766T (pt) Composições e métodos de utilização de (r)-pramipexole
HUS1900009I1 (hu) Új vegyületek és készítmények, továbbá alkalmazási eljárásaik
PL2101766T3 (pl) Kompozycje i sposoby stosowania (R)-pramipeksolu
EP2334185A4 (en) COMPOSITIONS AND METHODS FOR USE OF (R) -PRAMIPEXOL
IL195619A0 (en) Compositions and methods for joininig non-conjoined iumens
HRP20160902T1 (hr) Pripravci i postupci uporabe forbolskih estera
EP2101731A4 (en) PROCESSES AND COMPOSITIONS WITH END OXIFES
PL2069467T3 (pl) Kompozycje wydzielające i sposoby stosowania
PL1816116T6 (pl) Kompozycje chemiczne i sposoby ich wytwarzania
ZA200902255B (en) Synthesis, methods of using, and compositions of cycloalkylmethylamines
IL201364A0 (en) Gas-effusing compositions and methods of making and using same
ZA200808533B (en) Cement-containing compositions and method of use
IL207827A0 (en) Apoaequorin-containing compositions and methods of using same
IL192564A0 (en) Composition and method of use thereof
GB0617171D0 (en) Novel compositions and methods
EP2046109A4 (en) PHOTOSYNTHETIC ORGANISMS, COMPOSITIONS AND METHODS FOR GENERATING THESE ORGANISMS
IL192552A0 (en) Dnt-succinate and methods of preparation thereof
IL195845A0 (en) Methods of making and using rubidium-81-containing compositions
HK1134786A (en) Compositions and methods of using (r)-pramipexole
IL192588A0 (en) Cryoprotective compositions and methods of using same
ZA200806601B (en) Cryoprotective compositions and methods of using same
IL192614A0 (en) Antiseptic compositions and methods of using same
ZA200806668B (en) Antiseptic compositions and methods of using same
GB0616269D0 (en) Methods and compositions
GB0625230D0 (en) Compositions and methods